Krishnan V V, Thornton K H, Thelen M P, Cosman M
Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory, Livermore, California 94551, USA.
Biochemistry. 2001 Nov 6;40(44):13158-66. doi: 10.1021/bi010979g.
BRCT (BRCA1 carboxyl terminus) domains are found in a number of DNA repair enzymes and cell cycle regulators and are believed to mediate important protein-protein interactions. The DNA ligase IIIalpha BRCT domain partners with the distal BRCT domain of the DNA repair protein XRCC1 (X1BRCTb) in the DNA base excision repair (BER) pathway. To elucidate the mechanisms by which these two domains can interact, we have determined the solution structure of human ligase IIIalpha BRCT (L3[86], residues 837-922). The structure of L3[86] consists of a beta2beta1beta3beta4 parallel sheet with a two-alpha-helix bundle packed against one face of the sheet. This fold is conserved in several proteins having a wide range of activities, including X1BRCTb [Zhang, X. D., et al. (1998) EMBO J. 17, 6404-6411]. L3[86] exists as a dimer in solution, but an insufficient number of NOE restraints precluded the determination of the homodimer structure. However, 13C isotope-filtered and hydrogen-deuterium exchange experiments indicate that the N-terminus, alpha1, the alpha1-beta2 loop, and the three residues following alpha2 are involved in forming the dimer interface, as similarly observed in the structure of X1BRCTb. NOE and dynamic data indicate that several residues (837-844) in the N-terminal region appear to interconvert between helix and random coil conformations. Further studies of other BRCT domains and of their complexes are needed to address how these proteins interact with one another, and to shed light on how mutations can lead to disruption of function and ultimately disease.
BRCT(BRCA1羧基末端)结构域存在于多种DNA修复酶和细胞周期调节因子中,被认为可介导重要的蛋白质-蛋白质相互作用。在DNA碱基切除修复(BER)途径中,DNA连接酶IIIα的BRCT结构域与DNA修复蛋白XRCC1的远端BRCT结构域(X1BRCTb)相互作用。为阐明这两个结构域相互作用的机制,我们测定了人连接酶IIIα BRCT(L3[86],残基837 - 922)的溶液结构。L3[86]的结构由一个β2β1β3β4平行片层和一个双α螺旋束组成,该螺旋束堆积在片层的一个面上。这种折叠结构在多种具有广泛活性的蛋白质中保守,包括X1BRCTb [Zhang, X. D., et al. (1998) EMBO J. 17, 6404 - 6411]。L3[86]在溶液中以二聚体形式存在,但由于NOE限制数量不足,无法确定同型二聚体结构。然而,13C同位素过滤和氢-氘交换实验表明,N末端、α1、α1-β2环以及α2之后的三个残基参与形成二聚体界面,这与在X1BRCTb结构中观察到的情况类似。NOE和动力学数据表明,N末端区域的几个残基(837 - 844)似乎在螺旋构象和无规卷曲构象之间相互转换。需要对其他BRCT结构域及其复合物进行进一步研究,以探讨这些蛋白质如何相互作用,并阐明突变如何导致功能破坏并最终引发疾病。